TY  - JOUR
AU  - Daskalakis, Michael
AU  - Feller, Anita
AU  - Noetzli, Jasmine
AU  - Bonadies, Nicolas
AU  - Arndt, Volker
AU  - Baerlocher, Gabriela Maria
AU  - The Nicer Working Group
TI  - Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017.
JO  - Cancers
VL  - 13
IS  - 24
SN  - 2072-6694
CY  - Basel
PB  - MDPI
M1  - DKFZ-2021-03246
SP  - 6269
PY  - 2021
AB  - Tyrosine kinase inhibitors (TKI) substantially improved chronic myeloid leukemia (CML) prognosis. We aimed to describe time period- and age-dependent outcomes by reporting real-world data of CML patients from Switzerland.Population-based incidence, mortality, and survival were assessed for four different study periods and age groups on the basis of aggregated data from Swiss Cantonal Cancer Registries.A total of 1552 new CML cases were reported from 1995 to 2017. The age-standardized rate (ASR) for the incidence remained stable, while the ASR for mortality decreased by 50-80
KW  - CML (Other)
KW  - incidence (Other)
KW  - mortality (Other)
KW  - relative survival (Other)
KW  - tyrosine kinase inhibitor (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:34944892
DO  - DOI:10.3390/cancers13246269
UR  - https://inrepo02.dkfz.de/record/178299
ER  -